Trials / Completed
CompletedNCT06872814
Vaccine Hesitancy in Patients with Solid Tumors: a Cross-sectional Single-center Survey
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 309 (actual)
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Cancer patients have a well-known and higher risk of vaccine-preventable disease (VPD) than the general population. VPD can cause serious complications due to compromised immune system, malnutrition and the same oncology treatments and represent a severe financial burden with a delay in treating the underlying cancer The main purpose of this survey is to analyse the perception of cancer patients on the topic vaccines and vaccine-preventable diseases, the acceptability of vaccines and the evaluation of the determining factors associated with the choice of the patient to be vaccinated or not. This information will be used to improve the management of these issues.
Conditions
Timeline
- Start date
- 2024-05-31
- Primary completion
- 2024-08-26
- Completion
- 2024-08-26
- First posted
- 2025-03-12
- Last updated
- 2025-03-17
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06872814. Inclusion in this directory is not an endorsement.